BioRestorative Therapies, Inc.
BRTX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001505497
No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in BioRestorative Therapies, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q3 2024
- Shares held
- 283.6K
- +11.4K (+4.2%) vs. Q3 2024
- Total value
- $405.6K
- −$66.4K (−14.1%) vs. Q3 2024
- New holders
- 2
- 3 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.00M |
| Q1 2026 | 14 | $184.2K |
| Q4 2025 | 16 | $383.4K |
| Q3 2025 | 17 | $550.3K |
| Q2 2025 | 18 | $413.9K |
| Q1 2025 | 17 | $501.8K |
| Q4 2024 | 17 | $405.6K |
| Q3 2024 | 17 | $471.9K |
| Q2 2024 | 15 | $520.0K |
| Q1 2024 | 15 | $531.0K |
| Q4 2023 | 15 | $540.9K |
| Q3 2023 | 15 | $648.7K |
| Q2 2023 | 14 | $1.42M |
| Q1 2023 | 17 | $1.02M |
| Q4 2022 | 18 | $900.4K |
| Q3 2022 | 19 | $1.16M |
| Q2 2022 | 16 | $975.1K |
| Q1 2022 | 17 | $1.80M |
| Q4 2021 | 13 | $1.72M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 2 | $12.0K |
| Q1 2021 | 1 | $30.0K |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding BioRestorative Therapies, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 54,722 | $78.3K | 0.00% | −984−1.8% | Reduced |
| StoneX Group Inc. | 50,143 | $71.7K | 0.00% | −2,386−4.5% | Reduced |
| Wealth Alliance | 40,000 | $57.2K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 27,500 | $39.3K | 0.00% | +10,000+57.1% | Added |
| Citadel Advisors LLC | 21,481 | $30.7K | 0.00% | +21,481 | New |
| Vanguard Group Inc | 20,472 | $29.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,459 | $29.3K | 0.00% | 00.0% | Unchanged |
| US Financial Advisors, LLC | 17,142 | $24.5K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 16,297 | $23.3K | 0.00% | +15,604+2,251.7% | Added |
| Newman Dignan & Sheerar, Inc. | 11,522 | $16.5K | 0.00% | +1,000+9.5% | Added |
| Advisor Group Holdings, Inc. | 2,193 | $3.13K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,577 | $2.25K | 0.00% | −574−26.7% | Reduced |
| SBI Securities Co., Ltd. | 60 | $86 | 0.00% | +60 | New |
| Bank of America Corp | 42 | $60 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,774−100.0% | Sold out |